Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Cancer Treatment Reports|June 1, 1976
Nitrosoureas in the management of disseminated malignant melanomaD L AhmannCancer|January 1, 1995
Estrogen replacement therapy withdrawal and regression of metastatic breast cancerM V Dhodapkar, J N Ingle, D L AhmannOncology|January 1, 1976
Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancerR T Eagan, D L Ahmann, H F BiselCancer Chemotherapy Reports|June 1, 1972
Clinical evaluation of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxam-ide (NSC-45388), melphalan (NSC-8806), and hydroxyurea (NSC-32065) in the treatment of disseminated malignant melanomaD L Ahmann, R G Hahn, H F BiselCancer Chemotherapy and Pharmacology|January 1, 1987
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patientsG Powis, P Reece, D L Ahmann, et al.The Journal of Investigative Dermatology|December 1, 1990
Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigationsE T Creagan, D J Schaid, D L Ahmann, et al.American Journal of Clinical Oncology|December 1, 1988
Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term respondersE T Creagan, D J Schaid, D L Ahmann, et al.Controlled Clinical Trials|June 1, 1988
A design for phase II testing of anticancer agents within a phase III clinical trialD J Schaid, J N Ingle, S Wieand, et al.Cancer|December 15, 1988
A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanomaE T Creagan, C L Loprinzi, D L Ahmann, et al.Pageof 6